ATTBF
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2019 Q4 | -0.00 | $226,267 | -$1M |
| 2019 Q3 | -0.00 | $127,792 | $7M |
| 2019 Q2 | -0.00 | $2,174 | -$607,475 |
| 2018 Q1 | -0.00 | $643 | -$1M |
| 2018 Q4 | -0.13 | $2,469 | -$1M |
| 2018 Q3 | -0.02 | $237 | -$4M |
| 2018 Q2 | -0.04 | $5,665 | -$440,994 |
| 2017 Q1 | -0.03 | $0 | -$3M |